Childhood vaccination against varicella: persistence of antibody, duration of protection, and vaccine efficacy.
about
Vaccines for post-exposure prophylaxis against varicella (chickenpox) in children and adultsVaccines for post-exposure prophylaxis against varicella (chickenpox) in children and adultsPrimary versus secondary failure after varicella vaccination: implications for interval between 2 dosesDeclining incidence of chickenpox in the absence of universal childhood immunisationVaricella zoster virus: vaccination and implications in children with renal failure.Review of the Varilrix varicella vaccine.Economic evaluation of vaccines: specificities and future challenges illustrated by recent European examples.Modelling the impact of one-dose vs. two-dose vaccination regimens on the epidemiology of varicella zoster virus in Australia.
P2860
Q24193819-1B543D2C-2CA0-4D3F-95CA-6C68A27DF7B5Q24242809-218FECD0-4FF3-44AE-AAF8-C62630EDB54CQ33880341-39C78818-FD59-4981-AA09-0CE0E4A4344BQ35277040-F98F431B-8789-4354-BD0A-98A702F8E90FQ35791770-1A99F170-9175-4051-92A6-4B73C9A30BECQ36284539-1A580331-6186-4982-889D-0BA434658FF4Q38105340-9C5EB70E-22D4-41B0-ADED-989898C03F18Q51790294-1B1C3879-EDC4-482D-9F4D-504C02F2B7A1
P2860
Childhood vaccination against varicella: persistence of antibody, duration of protection, and vaccine efficacy.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Childhood vaccination against ...... tection, and vaccine efficacy.
@en
Childhood vaccination against ...... tection, and vaccine efficacy.
@nl
type
label
Childhood vaccination against ...... tection, and vaccine efficacy.
@en
Childhood vaccination against ...... tection, and vaccine efficacy.
@nl
prefLabel
Childhood vaccination against ...... tection, and vaccine efficacy.
@en
Childhood vaccination against ...... tection, and vaccine efficacy.
@nl
P2093
P356
P1476
Childhood vaccination against ...... tection, and vaccine efficacy.
@en
P2093
Carfagno PA
Kutzler DP
Matthews H
P304
P356
10.1067/MPD.2001.116051
P407
P577
2001-08-01T00:00:00Z